Financhill
Back

EyePoint Pharmaceuticals Vs. Ocular Therapeutix Industry Stock Comparison

Sell
43

EYPT
EyePoint Pharmaceuticals

Last Price:
10.70
Seasonality Move:
-1.61%
Buy
61

OCUL
Ocular Therapeutix

Last Price:
5.69
Seasonality Move:
-3.25%
Sell
43
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $10.71. The Score for EYPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Ocular Therapeutix (OCUL) is a Buy

Is Ocular Therapeutix a Buy, Sell or Hold?

  • The current Ocular Therapeutix [OCUL] share price is $5.70. The Score for OCUL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • OCUL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $10.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.

OCUL Stock Price Chart

What is Ocular Therapeutix's stock price today?

  • The Ocular Therapeutix share price today is $5.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCUL is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.78 Sell
Relative Strength Index (14 RSI): 30.67 Sell
Chaikin Money Flow: 275728 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.36 - 16.2) Sell
Bollinger Bands (100): (15.47 - 26.81) Sell

OCUL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 42.11 Sell
Chaikin Money Flow: -1294659 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.31 - 6.21) Sell
Bollinger Bands (100): (4.79 - 9.01) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.11 Sell
20-day SMA: 12.11 Sell
50-day SMA: 16.78 Sell
200-day SMA: 16.31 Sell
8-day EMA: 11.18 Sell
20-day EMA: 12.59 Sell
50-day EMA: 15.87 Sell
200-day EMA: 16.34 Sell

OCUL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.87 Sell
20-day SMA: 5.94 Sell
50-day SMA: 6.73 Sell
200-day SMA: 5.08 Buy
8-day EMA: 5.86 Sell
20-day EMA: 5.95 Sell
50-day EMA: 6.41 Sell
200-day EMA: 5.8 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.85 per share.

Ocular Therapeutix Earnings Growth & OCUL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.20 per share, and an increase next year of $0.20 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ocular Therapeutix Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):